- Home
- SND vs NKTR Comparison
SND vs NKTR Comparison
Compare SND & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SND
- NKTR
- Stock Information
- Founded
- SND 2011
- NKTR 1990
- Country
- SND United States
- NKTR United States
- Employees
- SND N/A
- NKTR N/A
- Industry
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- SND Industrials
- NKTR Health Care
- Exchange
- SND Nasdaq
- NKTR Nasdaq
- Market Cap
- SND 91.3M
- NKTR 108.3M
- IPO Year
- SND 2016
- NKTR 1994
- Fundamental
- Price
- SND $2.05
- NKTR $24.25
- Analyst Decision
- SND Hold
- NKTR Strong Buy
- Analyst Count
- SND 1
- NKTR 6
- Target Price
- SND $2.25
- NKTR $81.67
- AVG Volume (30 Days)
- SND 83.3K
- NKTR 4.8M
- Earning Date
- SND 08-12-2025
- NKTR 08-07-2025
- Dividend Yield
- SND 4.83%
- NKTR N/A
- EPS Growth
- SND N/A
- NKTR N/A
- EPS
- SND N/A
- NKTR N/A
- Revenue
- SND $293,878,000.00
- NKTR $87,248,000.00
- Revenue This Year
- SND N/A
- NKTR N/A
- Revenue Next Year
- SND N/A
- NKTR N/A
- P/E Ratio
- SND N/A
- NKTR N/A
- Revenue Growth
- SND N/A
- NKTR N/A
- 52 Week Low
- SND $1.73
- NKTR $6.48
- 52 Week High
- SND $2.80
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- SND 55.50
- NKTR 63.40
- Support Level
- SND $1.91
- NKTR $21.87
- Resistance Level
- SND $2.04
- NKTR $26.59
- Average True Range (ATR)
- SND 0.08
- NKTR 4.14
- MACD
- SND -0.00
- NKTR 0.01
- Stochastic Oscillator
- SND 60.00
- NKTR 54.77
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.